Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
binjurebarksinsufficiens).
adrenocortical insufficiency),
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 4
Qualità:
8 binjurebarksinsufficiens, njursvikt, andningsinsufficiens, pleurautgjutning, pneumothorax, chock och plötslig död.
fatal events other than those listed in section 4.4 above or section 4.8 below that were considered possibly related to sutent included multi-system organ failure, disseminated intravascular coagulation, peritonoeal haemorrhage, rhabdomyolysis, cerebrovascular accident, dehydration, adrenal insufficiency, renal failure, respiratory failure, pleural effusion, pneumothorax, shock, and sudden death.
försiktighet tillråds och binjurebarksinsufficiens ska övervakas om prednison eller prednisolon sätts ut hos en patient.
caution is advised and monitoring for adrenocortical insufficiency should occur if patients are withdrawn from prednisone or prednisolone.
särskilt bör patienten utredas för hypotyreos, binjurebarksinsufficiens, hyperprolaktinemi och hypofys- eller hypothalamustumörer, och adekvat behandling ges.
in particular, patients should be evaluated for hypothyroidism, adrenocortical insufficiency, hyperprolactinemia and pituitary or hypothalamic tumours, and appropriate specific treatment given.
vissa okompenserade endokrina störningar (t ex hypotyreoidism och främre hypofys- eller binjurebarksinsufficiens), samtidig behandling med vissa andra läkemedel.
certain uncompensated endocrine disorders (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency), concomitant treatment with certain other medicinal products.
vissa okompenserade endokrina störningar (t ex hypotyreoidism och främre hypofys- eller binjurebarksinsufficiens), samtidig behandling med vissa andra läkemedel (se avsnitt 4.5).
certain uncompensated endocrine disorders (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency), concomitant treatment with certain other medicinal products (see section 4.5).